Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries. | Academic Article |
Why?
|
The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. | Academic Article |
Why?
|
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. | Academic Article |
Why?
|
Schizophrenia and substance abuse: Is schizophrenia forgotten? | Academic Article |
Why?
|
Schizophrenia among first-degree relatives of paranoid and nonparanoid schizophrenics. | Academic Article |
Why?
|
Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. | Academic Article |
Why?
|
Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. | Academic Article |
Why?
|
The significance of age of onset for schizophrenia. | Academic Article |
Why?
|
Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia. | Academic Article |
Why?
|
Emotional response as a function of symptoms in schizophrenia. | Academic Article |
Why?
|
Search for a genetic event in monozygotic twins discordant for schizophrenia. | Academic Article |
Why?
|
Family therapy for schizophrenia: co-occurring psychotic and substance use disorders. | Academic Article |
Why?
|
A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. | Academic Article |
Why?
|
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. | Academic Article |
Why?
|
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. | Academic Article |
Why?
|